Screener
Journey Medical Corporation DERM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Journey Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Journey Medical Corporation’s 10-Q, filed August 12, 2026. Open the filing →
- Filed
- Aug 12, 2026, 4:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-094948
FAQ
- What is Journey Medical Corporation's EPS (diluted)?
- Journey Medical Corporation (DERM) reported EPS (diluted) of -$0.01 in Q2 2026.
- How has Journey Medical Corporation's EPS (diluted) changed year-over-year?
- Journey Medical Corporation's EPS (diluted) increased by 93.8% year-over-year, from -$0.16 to -$0.01.
- What is the long-term trend for Journey Medical Corporation's EPS (diluted)?
- Over 3 years (2021 to 2025), Journey Medical Corporation's EPS (diluted) has grown at a -52.3% compound annual growth rate (CAGR), from -$4.33 to -$0.47.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Journey Medical Corporation's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude